Calton & Associates’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-236
Closed -$32K 372
2017
Q4
$32K Buy
+236
New +$32K 0.01% 788